On the recordOctober 11, 2017
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of S. 920, the National Clinical Care Commission Act. Mr. Speaker, this legislation aims to help improve Federal efforts to treat and to prevent metabolic and autoimmune disorders related to insulin. The most common metabolic disorder in the U.S. is diabetes, which affects more than 25 million Americans. Another 86 million Americans have prediabetes, a condition associated with an increased risk of developing type 2 diabetes and heart disease. Mr. Speaker, diabetes takes a huge toll on human health; in fact, it is the seventh leading cause of death in our Nation. Additionally, Mr. Speaker, all too often diabetes leads to avoidable complications, such as blindness, such as limb amputation, and also kidney failure. In addition to the effects on human health, Mr. Speaker, diabetes care makes up a large percentage of U.S. healthcare expenditure. Mr. Speaker, currently $1 of every $5 of healthcare cost is spent caring for people with diabetes. The proportion of Medicare funding is even greater than this. Currently, $1 of every $3 of Medicare expenditure is spent caring for people with diabetes. {time} 1500 Mr. Speaker, that is why it is important to improve the Federal efforts that prevent avoidable cases of diabetes and other metabolic disorders, and to ensure that all Americans have the treatment and the management services necessary to successfully manage this and other similar conditions.…





